Mostyn Law Says FDA Surgical Mesh Warning Falls Short

HOUSTON, April 1, 2016 /PRNewswire-USNewswire/ -- Amber Mostyn of Mostyn Law had this to say in response to the FDA's safety alert issued today regarding Boston Scientific's counterfeit surgical mesh:

"The FDA's watered-down warning of the risk posed by Boston Scientific's surgical mesh falls far short of what is needed to protect women's health. We are talking about a counterfeit version of a product that the original U.S. manufacturer has repeatedly said should not be used in the human body. You don't test a counterfeit product from China, you throw it out. No amount of testing can possibly confirm that this counterfeit version is acceptable for use in surgical mesh, and it is absurd to rely on testing by the company that is using it. The FDA should fulfill its mission to protect public health by taking this dangerous product off the market immediately." 

SOURCE Mostyn Law